Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily versus divided-dose metronidazole with gentamicin in pediatric appendicitis
RBR-95gbvmqPhase 3Recruiting
- Sponsor
- IMIP
- Start
- Jan 2022
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metronidazole and gentamicin in acute appendicitis (2 arms), sponsored by IMIP. Started Jan 2022; status: recruiting.
02
Drugs
metronidazolegentamicin
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on RBR-95gbvmq.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-95gbvmq.